NCT00191009 - Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

January 31, 2006

Conditions

Alzheimer Disease

Interventions

DRUG

atomoxetine hydrochloride

DRUG

placebo

Trial Locations (3)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Sherman Oaks

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Rochester

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Wichita Falls